FDA advisers: Popular nasal decongestant doesn't actually relieve congestion

If the FDA follows through on the panel’s recommendations, Johnson & Johnson, Bayer and other drugmakers could be required to pull their oral medications containing phenylephrine from store shelves.

Related Keywords

United States ,Oklahoma ,Washington ,Americans ,Jennifer Schwartzott ,Mark Dykewicz ,Peter Starke ,Theresa Michele ,Paul Pisaric ,Consumer Healthcare Products Association ,Saint Louis University School Of Medicine ,Archwell Health ,University Of Florida ,Johnson ,Drug Administration ,Saint Louis University School ,Business ,Health ,